Cover Image
市場調查報告書

美國的心臟血管手術設備市場預測

United States Cardiovascular Surgery Market Outlook to 2020

出版商 GlobalData 商品編碼 302396
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
Back to Top
美國的心臟血管手術設備市場預測 United States Cardiovascular Surgery Market Outlook to 2020
出版日期: 2014年05月09日 內容資訊: 英文 144 Pages
簡介

本報告提供美國的心臟血管手術設備市場相關資料,提供心臟不停跳手術用系統,心臟燒灼設備,心肺體外循環設備,拋棄式灌流設備等各類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再彙整主要企業簡介,開發中產品,主要的財務相關交易的最新資訊等等,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 心臟血管手術設備市場區分
  • 該報告對象市場定義

第3章 美國的心臟血管手術設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Medtronic, Inc.
  • Maquet Holding B.V. & Co. KG.
  • Sorin S.p.A.
  • Terumo Corporation

第5章 心臟血管手術設備市場開發中產品

第6章 財務交易情勢

  • 收購
  • 發行公司債券
  • 股票上市
  • 聯盟
  • 創業融資

第7章 最新趨勢

  • 企業通訊
  • 財務發表
  • 政府·公益相關
  • 法律規章
  • 其他重要的動向
  • 產品資訊
  • 研究開發
  • 策略及產業規劃

第8章 附錄

圖表

目錄
Product Code: GDMECC0335DB

GlobalData's new report, "United States Cardiovascular Surgery Market Outlook to 2020", provides key market data on the United States Cardiovascular Surgery Market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Surgery Market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiovascular Surgery Devices categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the United States Cardiovascular Surgery Market.
  • Key players covered include Medtronic, Inc., MAQUET GmbH & Co. KG, Sorin Group and Terumo Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiovascular Surgery Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiovascular Surgery Market, United States

  • 3.1. Cardiovascular Surgery Market, United States, Revenue ($m), 2005-2012
  • 3.2. Cardiovascular Surgery Market, United States, Revenue ($m), 2012-2020
    • 3.2.1. Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2005-2012
    • 3.2.2. Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2005-2012
    • 3.2.3. Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2012-2020
    • 3.2.4. Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2012-2020
  • 3.3. Cardiovascular Surgery Market, United States, Volume (Units), 2005-2012
  • 3.4. Cardiovascular Surgery Market, United States, Volume (Units), 2012-2020
    • 3.4.1. Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2005-2012
    • 3.4.2. Perfusion Disposables Market, United States, Volume (Units), by Segment, 2005-2012
    • 3.4.3. Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2012-2020
    • 3.4.4. Perfusion Disposables Market, United States, Volume (Units), by Segment, 2012-2020
  • 3.5. Cardiovascular Surgery Market, United States, Average Price ($), 2005-2020
  • 3.6. Cardiovascular Surgery Market, United States, Distribution Share by Revenue ($m), 2011-2012
  • 3.7. Cardiovascular Surgery Market, United States, Company Share by Revenue ($m), 2011-2012

4. Overview of Key Companies in United States, Cardiovascular Surgery Market

  • 4.1. Medtronic, Inc.
    • 4.1.1. Company Overview
  • 4.2. Maquet Holding B.V. & Co. KG.
    • 4.2.1. Company Overview
  • 4.3. Sorin S.p.A.
    • 4.3.1. Company Overview
  • 4.4. Terumo Corporation
    • 4.4.1. Company Overview

5. Cardiovascular Surgery Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For US$14 Million
  • 6.2. Debt Offerings
    • 6.2.1. Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million
    • 6.2.2. Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million
    • 6.2.3. Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million
    • 6.2.4. Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million
    • 6.2.5. Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion
    • 6.2.6. Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million
    • 6.2.7. Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion
  • 6.3. Equity Offerings
    • 6.3.1. Cardica Prices Public Offering Of Preferred Stock For US$16.3 Million
    • 6.3.2. Cardica Completes Public Offering Of Shares For US$31.8 Million
    • 6.3.3. Cardica Completes Public Offering Of Shares For US$15 Million
  • 6.4. Partnerships
    • 6.4.1. Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse
    • 6.4.2. Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems
    • 6.4.3. Minnetronix Enters Into Licensing Agreement With Penn State Research Foundation For Wireless Energy Transmission Technology
  • 6.5. Venture Financing
    • 6.5.1. Tenaxis Medical Raises US$1.4 Million In Venture Financing
    • 6.5.2. Medrobotics Raises US$21.3 Million In Venture Financing
    • 6.5.3. BioVentrix Raises US$0.5 Million In Venture Financing
    • 6.5.4. CHF Technologies Raises US$0.8 Million In Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Feb 18, 2014: SurModics Announces Changes to Board of Directors
    • 7.1.2. Jan 13, 2014: Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
    • 7.1.3. Dec 04, 2013: Cook Medical Names Rob Lyles Executive Vice President
    • 7.1.4. Dec 04, 2013: Mark Breedlove Named Vice President of Cook Medical's Peripheral Intervention Clinical Division
    • 7.1.5. Oct 01, 2013: Gretchen Gutman Named Vice President of Public Policy for Cook Group
    • 7.1.6. Sep 23, 2013: BioVentrix Appoints Cardiology Expert Dr. Serjan Nikolic as Vice President of Therapy Development
    • 7.1.7. Sep 20, 2013: SurModics Announces Board Changes
    • 7.1.8. Aug 22, 2013: Nicky James Named Vice President and Global Leader of Cook Medical Aortic Intervention Clinical Division
    • 7.1.9. Jul 09, 2013: CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager
  • 7.2. Financial Announcements
    • 7.2.1. May 01, 2014: Cardica Announces Fiscal 2014 Third Quarter Financial Results
    • 7.2.2. May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results
    • 7.2.3. Apr 24, 2014: Merit Medical Reports Sales Up 15% for the Quarter Ended March 31, 2014
    • 7.2.4. Feb 24, 2014: Merit Medical Reports Record Revenues for the Quarter and Year Ended December 31, 2013
    • 7.2.5. Feb 20, 2014: CryoLife Fourth Quarter 2013 Revenues Increased 8 Percent to a Record $35.5 Million
    • 7.2.6. Feb 18, 2014: Medtronic Reports Third Quarter Earnings
    • 7.2.7. Feb 04, 2014: Cardica Announces Fiscal 2014 Second Quarter Financial Results
    • 7.2.8. Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results
    • 7.2.9. Nov 19, 2013: Medtronic Reports Second Quarter Earnings
    • 7.2.10. Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014
    • 7.2.11. Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results
    • 7.2.12. Nov 04, 2013: Cardica Announces Fiscal 2014 First Quarter Financial Results
    • 7.2.13. Oct 29, 2013: CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million
    • 7.2.14. Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5
    • 7.2.15. Oct 23, 2013: Merit Medical Announces Results for the Quarter Ended September 30, 2013
    • 7.2.16. Oct 21, 2013: Cardica To Announce Fiscal 2014 First Quarter Financial Results On Monday, November 4, 2013
    • 7.2.17. Oct 14, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Third Quarter Financial Results
    • 7.2.18. Oct 07, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Third Quarter Ended September 30, 2013
    • 7.2.19. Aug 20, 2013: Medtronic Reports First Quarter Earnings
    • 7.2.20. Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014
    • 7.2.21. Aug 05, 2013: Cardica Announces Fiscal 2013Fourth Quarter And Full Year Financial Results
    • 7.2.22. Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results
    • 7.2.23. Jul 31, 2013: Merit Medical Reports Record Revenues, up Nine Percent, for the Quarter and Six Months Ended June 30, 2013
    • 7.2.24. Jul 25, 2013: CryoLife Reports Record Second Quarter Revenues
    • 7.2.25. Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31
    • 7.2.26. Jul 22, 2013: Cardica to Announce Fiscal 2013 Fourth Quarter and Full Year Financial Results On Monday, August 5, 2013
    • 7.2.27. Jul 11, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
    • 7.2.28. Jul 11, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
    • 7.2.29. Jul 08, 2013: Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2013
    • 7.2.30. May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013
    • 7.2.31. May 07, 2013: SurModics Reports Second Quarter Fiscal 2013 Results
  • 7.3. Government and Public Interest
    • 7.3.1. Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
    • 7.3.2. Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference
    • 7.3.3. Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference
    • 7.3.4. Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference
    • 7.3.5. Nov 26, 2013: Medtronic EVP & President Mike Coyle to Speak at Piper Jaffray Healthcare Conference
    • 7.3.6. Nov 26, 2013: Merit Medical to Participate at Piper Jaffray Healthcare Conference
    • 7.3.7. Nov 25, 2013: CryoLife to Present at 25th Annual Piper Jaffray Healthcare Conference
    • 7.3.8. Nov 12, 2013: Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Week
    • 7.3.9. Nov 12, 2013: SurModics to Present at Canaccord Genuity Medical Technology & Diagnostics Conference
    • 7.3.10. Sep 11, 2013: Cardica To Present At Craig-Hallum Alpha Select Conference
    • 7.3.11. Sep 06, 2013: Medtronic CFO Gary Ellis to Speak at Morgan Stanley Healthcare Conference
    • 7.3.12. Sep 03, 2013: Merit Medical to Present at CL King Conference
    • 7.3.13. Aug 27, 2013: SurModics to Present at CL King's Best Ideas Conference
    • 7.3.14. Aug 07, 2013: Cardica to Present at Wedbush 2013 Life Sciences Management Access Conference
    • 7.3.15. Aug 01, 2013: Merit Medical to Participate at Canaccord Genuity Growth Conference
    • 7.3.16. May 21, 2013: SurModics to Present at the Jefferies Global Healthcare Conference
  • 7.4. Legal And Regulatory
    • 7.4.1. Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve
    • 7.4.2. Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test
    • 7.4.3. Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures
    • 7.4.4. Oct 19, 2013: Medtronic Statement on Medical Device Security
    • 7.4.5. Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records
    • 7.4.6. Jul 01, 2013: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc.
    • 7.4.7. May 29, 2013: Edwards Lifesciences Gets FDA Warning Letter Regarding Cardiac Surgery Systems
  • 7.5. Other Significant Developments
    • 7.5.1. Feb 24, 2014: Cesca Therapeutics and Cook Medical Enter Supply Agreement for a Phase 1b Clinical Trial
    • 7.5.2. Feb 19, 2014: CryoLife Announces Quarterly Cash Dividend for the First Quarter 2014
    • 7.5.3. Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014
    • 7.5.4. Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai
    • 7.5.5. Jan 27, 2014: Saint Luke's awarded $3.4 million grant from Boston Scientific for further research into innovative cardiac procedures
    • 7.5.6. Dec 16, 2013: Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases
    • 7.5.7. Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles
    • 7.5.8. Nov 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013
    • 7.5.9. Sep 03, 2013: SurModics Announces Organizational Changes
    • 7.5.10. Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014
    • 7.5.11. Aug 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2013
    • 7.5.12. Jul 22, 2013: SurModics to Present at the InvestMNt Conference
    • 7.5.13. Jul 12, 2013: Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Vascular Closure Devices
  • 7.6. Product News
    • 7.6.1. Nov 18, 2013: New Study May Impact Practice Guidelines for Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation
    • 7.6.2. Nov 18, 2013: LVAD Patients Benefit from Heart Injection with Millions of Powerful Cells
    • 7.6.3. Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall
    • 7.6.4. Nov 14, 2013: Endovascular Aneurysm Training Module Now Supports Vascutek's Anaconda Devices
  • 7.7. Research And Development
    • 7.7.1. May 30, 2013: Cook Medical Joins With Indiana Life Science Businesses, Academia And Government To Help Launch Bioscience Research Center
  • 7.8. Strategy And Business Planning
    • 7.8.1. Mar 15, 2014: Merit Medical Opens Office in Bangalore, India
    • 7.8.2. Feb 04, 2014: Purdue Research Foundation, Cook Medical partner on $12 million project to support life sciences startup opportunities
    • 7.8.3. Nov 14, 2013: Cook Medical Opens New Innovation Centre in Limerick, Ireland
    • 7.8.4. Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland
    • 7.8.5. Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies
    • 7.8.6. Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 2: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 5: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 6: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 7: Cardiovascular Surgery Market, United States, Volume (Units), Historic, 2005-2012
  • Table 8: Cardiovascular Surgery Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 9: Beating Heart Surgery Systems Market, United States, Volume (Units), Historic, 2005-2012
  • Table 10: Perfusion Disposables Market, United States, Volume (Units), Historic, 2005-2012
  • Table 11: Beating Heart Surgery Systems Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 12: Perfusion Disposables Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 13: Cardiovascular Surgery Market, United States, Average Price ($), Historic, 2005-2012
  • Table 14: Cardiovascular Surgery Market, United States, Average Price ($), Forecast, 2012-2020
  • Table 15: Cardiovascular Surgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 16: Cardiovascular Surgery Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 17: Cardiovascular Surgery Market Pipeline Products
  • Table 18: Sorin Acquires California Medical Labs, Maker Of Cardiovascular Cannulae, For US$14 Million
  • Table 19: Medtronic Completes Public Offering Of Notes Due 2017 For US$250 Million
  • Table 20: Medtronic Completes Public Offering Of 0.875% Notes Due 2017 For US$250 Million
  • Table 21: Medtronic Completes Public Offering Of Notes Due 2024 For US$850 Million
  • Table 22: Medtronic Completes Public Offering Of Notes Due 2044 For US$650 Million
  • Table 23: Medtronic Completes Public Offering Of Notes Due 2018 For US$1 Billion
  • Table 24: Medtronic Completes Public Offering Of Notes Due 2043 For US$750 Million
  • Table 25: Medtronic Completes Public Offering Of Notes Due 2023 For US$1.25 Billion
  • Table 26: Cardica Prices Public Offering Of Preferred Stock For US$16.3 Million
  • Table 27: Cardica Completes Public Offering Of Shares For US$31.8 Million
  • Table 28: Cardica Completes Public Offering Of Shares For US$15 Million
  • Table 29: Sun Biomedical Plans To Enter Into Licensing Agreement With Parvulus Suisse
  • Table 30: Xenios Enters Into Licensing Agreement With Leukocare For Next Generation Extracorporeal Support Systems
  • Table 31: Minnetronix Enters Into Licensing Agreement With Penn State Research Foundation For Wireless Energy Transmission Technology
  • Table 32: Tenaxis Medical Raises US$1.4 Million In Venture Financing
  • Table 33: Medrobotics Raises US$21.3 Million In Venture Financing
  • Table 34: BioVentrix Raises US$0.5 Million In Venture Financing
  • Table 35: CHF Technologies Raises US$0.8 Million In Venture Financing
  • Table 36: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 2: Cardiovascular Surgery Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 5: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 6: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 7: Cardiovascular Surgery Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 8: Cardiovascular Surgery Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 9: Beating Heart Surgery Systems Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 10: Perfusion Disposables Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 11: Beating Heart Surgery Systems Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 12: Perfusion Disposables Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 13: Cardiovascular Surgery Market, United States, Company Share (%) 2012
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top